Top Consumer Driven Health Care Stories
Low-income patients struggle to afford high-priced GLP-1 diabetes drugs
By Renuka RayasamOzempic, Trulicity and Mounjaro were first approved to treat diabetes, however, in the last three years, the FDA has approved rebranded versions of Mounjaro and Ozempic for weight loss, leading demand – and prices – to skyrocket.










